Increasing accumulation of fat, inflammation and fibrosis of the liver appear tied to corresponding increases in the risk of cardiovascular disease, especially in patients with diabetes, according to the findings of a study. Nnonalcoholic fatty liver disease is adding extra cardiovascular risk to people with diabetes on top of that which is already existing and hence patients with documented liver disease perhaps require more aggressive therapies.
In the studies of 112 patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD), measure of NAFLD severity were found to be highly correlated with higher cardiovascular risk. There is increasing evidence of an increased cardiovascular risk associated with progression of nonalcoholic fatty liver disease.
Up until now most of the patients of NAFLD do not get proper attention in getting cardiovascular risk reduction treatments. Currently the only treatment strategy proven to work for NAFLD is lifestyle changes. Losing weight and increasing activity levels are very effective at decreasing liver fat. But what this study proves is that the patients might also require additional attention towards higher cardiovascular risk.
In the studies of 112 patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD), measure of NAFLD severity were found to be highly correlated with higher cardiovascular risk. There is increasing evidence of an increased cardiovascular risk associated with progression of nonalcoholic fatty liver disease.
Up until now most of the patients of NAFLD do not get proper attention in getting cardiovascular risk reduction treatments. Currently the only treatment strategy proven to work for NAFLD is lifestyle changes. Losing weight and increasing activity levels are very effective at decreasing liver fat. But what this study proves is that the patients might also require additional attention towards higher cardiovascular risk.
0 comments:
Post a Comment